Grassley Says FDA Problems Need Sunshine, Calls on Commissioner to Reverse Chill Factor
WASHINGTON — Sen. Chuck Grassley said that statements by the Commissioner of the Food and Drug Administration discourage agency employees and scientists from speaking up about problems with the way the FDA monitors drug safety in the United States and raise questions about what the FDA might be trying to hide. In a letter sent […]
Grassley Expresses Concern Over Federal Charitable Giving Program
WASHINGTON – Sen. Chuck Grassley, ranking member of the Committee on Finance, is expressing concern that management changes to the federal employees’ charitable giving program will undermine accountability from charities to donors and potentially discourage donations. Grassley continues a broad-ranging effort to strengthen charities overall by protecting them from those who would use them for […]
Grassley: House Democratic Leaders Fuss Over Halliburton but Slow-walk Corporate Loophole Closers
M E M O R A N D U M To: Reporters and Editors Re: Halliburton, corporate loophole closers Da: Monday, March 12, 2007 Sen. Chuck Grassley, ranking member of the Committee on Finance, today made the following comment on Halliburton’s move of its CEO to Dubai. “It’s interesting that some Democratic House leaders are […]
Grassley on U.S.-Brazil Agreement to Advance Biofuels
M E M O R A N D U M To: Reporters and Editors Fr: Jill Gerber for Sen. Grassley, 202/224-6522 Re: U.S.-Brazil cooperation on biofuels Da: Friday, March 9, 2007 Sen. Chuck Grassley, ranking member of the Committee on Finance, made the following comment on today’s U.S.-Brazil memorandum of understanding to advance cooperation on […]
Grassley’s Red Cross Modernization Bill Advances Via Committee
WASHINGTON – Sen. Chuck Grassley’s legislation to modernize the management structure of the American Red Cross has advanced through committee, clearing it for full Senate consideration. “The Red Cross does a very good job,” Grassley said. “It can do an even better job with some simple management improvements. The Red Cross is responsive to changes […]
Grassley Warns of Phony Revenue Offsets Masking Deficit Spending
Statement of Senator Chuck Grassley: Use of Revenue Raisers in Budget Resolution Thursday, March 8, 2007 Mr. President, today I’m going to continue on with my discussion of the issues the Senate will face as the Democratic Leadership draws up its budget resolution. We face an important milestone because the Democratic Leadership controls the Senate […]
Sen. Grassley’s Comment on the March 7, 2007 JAMA Article on Physician-Owned Specialty Hospitals
M E M O R A N D U M TO: Reporters and Editors FR: Jill Kozeny, 202/224-1308 for Senator Grassley RE: March 7, 2007 JAMA article regarding physician-owned specialty hospitals DA: March 8, 2007 Sen. Chuck Grassley issued the comment below about the analysis of specialty cardiac hospitals presented by Brahmajee K. Nallamothu, MD, […]
Baucus, Grassley Pursue Latest Lists of Tax Avoidance Tactics
WASHINGTON – Sen. Max Baucus, chairman of the Committee on Finance, and Sen. Chuck Grassley, ranking Republican member, have asked the Internal Revenue Service for an updated list of the newest, biggest tax avoidance scams – including those using nonprofit groups – that deserve the committee’s attention. The IRS’s prior responses to similar inquiries have […]
Grassley Expresses Disappointment Over Hedge Fund Registration Amendment Objection
Tonight, Senator Grassley attempted to offer his amendment giving the SEC statutory authority to register hedge funds to S. 4, the 9/11 commission recommendations bill. The bill manager objected, citing a backlog of pending amendments. Senator Grassley then submitted his prepared statement into the record, with an addition. The addition: I was not surprised by […]
Baucus, Grassley Ask FDA to Account for Findings of New Report
WASHINGTON — Sens. Max Baucus and Chuck Grassley have asked the Commissioner of the Food and Drug Administration to respond to a new independent review of the computing system used by the drug safety agency to conduct post-marketing surveillance of drugs and devices. The November 2006 report of the Breckenridge Institute hasn’t previously been made public. […]